Catalyst Wire Dossier Catalyst Wire Dossier

H7N1 influenza vaccine

influenza vaccine, subtype H7N1 · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H7N1 influenza vaccine, covering 2017-05-08 to 2017-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age [Phase 1]

See pricing